GSK 705498

Drug Profile

GSK 705498

Alternative Names: 705498; GSK-705498; SB-705498

Latest Information Update: 21 Jul 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator GlaxoSmithKline
  • Class Bromobenzenes; Non-opioid analgesics; Pyridines; Pyrrolidines; Small molecules
  • Mechanism of Action TRPV1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Allergic rhinitis; Atopic dermatitis; Cough; Dental pain; Migraine; Pain; Pruritus; Rhinitis

Most Recent Events

  • 31 Jul 2012 Phase-I clinical trials in Atopic dermatitis in United Kingdom (Topical)
  • 26 Jan 2012 GlaxoSmithKline completes a phase II trial in Cough in United Kingdom (NCT01476098)
  • 28 Sep 2011 Efficacy data from clinical trials in Rhinitis presented at the 21st Annual Congress of the European Respiratory Society (ERS-2011)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top